Royal DSM reported second quarter 2014 EBITDA from continuing operations of €293 million compared to €332 million in Q2 2013, and €272 million in Q1 2014. Nutrition showed improvement compared to the last two quarters. Performance Materials continued its encouraging underlying trend and delivered higher results. Polymer Intermediates was negatively impacted by lower caprolactam margins.
Commenting on the results, Feike Sijbesma, CEO/chairman of the DSM Managing Board, said: "DSM delivered improved results versus the first quarter, despite persistent currency headwinds. Performance Materials saw continued positive momentum in a number of end-markets, whereas Polymer Intermediates has seen weaker business conditions for caprolactam.
DSM Reports Q2 2014 Results
Published August 19, 2014
Related Breaking News
- BASF Divests Omega-3 Production Plant for Natural Fish Oils to Marine Ingredients
- PPG Showcases Liquid, Powder, Pretreatment, E-Coat Products at FABTECH 2014
- Lonza Industrial Solutions Strengthens Relationship with KODA Distribution Group
- Benjamin Moore & Co. Appoints Ron Schuller As Chief Marketing Officer
Related Paint & Coatings Manufacturer News